An Update From ASH 2016: Interferon Therapy for MPNs

An Update From ASH 2016: Interferon Therapy for MPNs

User Photo
P2Professional

3 years
633 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Is interferon or hydroxyurea (Hydrea) more effective as a treatment for polycythemia vera (PV)? MPN expert and researcher, Dr. Heinz Gisslinger, discusses the results from PROUD-PV Phase III study. He details the pros and cons of interferon versus hydroxyurea and how these findings will affect patients. Get email alerts | http://www.patientpower.info/alerts Subscribe on YouTube | http://www.youtube.com/patientpower Like on Facebook | http://www.fb.com/patientpower.info Follow on Twitter | http://www.twitter.com/patientpower Follow on Google+ | http://www.google.com/+patientpowerinfo
Up Next Autoplay